-急性缺血性脑中风诊断市场： - 2024-2030 年诊断剂、生殖细胞、生殖细胞预测

-急性缺血性脑中风诊断市场规模预计到2023年为19.8亿美元，2024年达到21亿美元，预计到2030年将达到30.2亿美元，复合年增长率为6.15%。

全球急性缺血性脑中风诊断市场

FPNV定位矩阵

FPNV定位矩阵对于评估急性缺血性脑中风诊断市场至关重要。我们检视与业务策略和产品满意度相关的关键指标，以对供应商进行全面评估。这种深入的分析使用户能够根据自己的要求做出明智的决策。根据评估，供应商被分为四个成功程度不同的像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市场占有率分析

市场占有率分析是一种综合工具，可以对急性缺血性脑中风诊断市场供应商的现状进行深入而深入的研究。全面比较和分析供应商在整体收益、基本客群和其他关键指标方面的贡献，以便更好地了解公司的绩效及其在争夺市场占有率时面临的挑战。此外，该分析还提供了对该行业竞争特征的宝贵见解，包括在研究基准年观察到的累积、分散主导地位和合併特征等因素。这种详细程度的提高使供应商能够做出更明智的决策并制定有效的策略，从而在市场上获得竞争优势。

该报告对以下几个方面提供了宝贵的见解：

1-市场渗透率：提供有关主要企业所服务的市场的全面资讯。

2-市场开拓：我们深入研究利润丰厚的新兴市场，并分析它们在成熟细分市场中的渗透率。

3- 市场多元化：提供有关新产品发布、开拓地区、最新发展和投资的详细资讯。

4-竞争力评估与资讯：对主要企业的市场占有率、策略、产品、认证、监管状况、专利状况、製造能力等进行全面评估。

5- 产品开发与创新：提供对未来技术、研发活动和突破性产品开发的见解。

-市场规模和 -规模和

1-急性缺血性脑中风诊断市场的市场规模和预测是多少？

2-急性缺血性脑中风诊断市场预测期间需要考虑投资的产品、细分市场、应用和领域有哪些？

3-急性缺血性脑中风诊断市场的技术趋势和法律规范是什么？

4-急性缺血性脑中风诊断市场主要供应商的市场占有率是多少？

5-进入急性缺血性脑中风诊断市场的合适型态和策略手段是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

• 市场动态
  • 促进因素
    • 全球急性中风病例不断增加
    • 消费者对早期临床诊断的高度偏好
    • 加速神经影像设施的发展
  • 抑制因素
    • 相关诊断设备成本高
  • 机会
    • 透过整合机器人技术和人工智慧进行进阶诊断
    • 先进诊断的持续研发活动
  • 任务
    • 缺乏技术专长与实务经验
• 市场区隔分析
• 市场趋势分析
• 高通膨的累积效应
• 波特五力分析
• 价值炼和关键路径分析
• 法律规范

第 6 章 – 按诊断分類的急性缺血性脑中风诊断市场

• 颈超音波检查
• 脑血管血管造影术
• CT检查
• 心臟超音波图
• 心电图测试
• 磁振造影

第 7 章 –急性缺血性脑中风诊断市场：依最终用途

• 医院
• 调查诊断中心

第8章：急性缺血性脑中风诊断市场

• 阿根廷
• 巴西
• 加拿大
• 墨西哥
• 美国

第9章：亚太地区急性缺血性脑中风诊断市场

• 澳洲
• 中国
• 印度
• 印尼
• 日本
• 马来西亚
• 菲律宾
• 新加坡
• 韩国
• 台湾
• 泰国
• 越南

第10章：急性缺血性脑中风诊断市场

• 丹麦
• 埃及
• 芬兰
• 法国
• 德国
• 以色列
• 义大利
• 荷兰
• 奈及利亚
• 挪威
• 波兰
• 卡达
• 俄罗斯
• 沙乌地阿拉伯
• 南非
• 西班牙
• 瑞典
• 瑞士
• 土耳其
• 阿拉伯聯合大公国
• 英国

第十一章竞争形势

• FPNV定位矩阵
• 市场占有率分析：主要企业
• 主要企业竞争情境分析

第12章竞争产品组合

• 主要公司简介
  • Abbott Laboratories
  • BIOTRONIK SE & Co KG
  • Boehringer Ingelheim International GmbH
  • Boston Scientific Corporation
  • Canon Medical Systems Corporation
  • F. Hoffmann-La Roche Ltd
  • Fujifilm Holdings Corporation
  • GE Healthcare Technologies Inc.
  • Genentech, Inc.
  • Hitachi, Ltd.
  • Integral Diagnostics（IDX）Group
  • Koninklijke Philips NV
  • Mediso Kft.
  • Medtronic PLC
  • Memorial Health
  • Neusoft Medical Systems Co., Ltd.
  • Nihon Kohden Corporation
  • Planmed Oy
  • Samsung Electronics Co. Ltd
  • Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • Shimadzu Corporation
  • Siemens Healthineers company
  • Stryker Corporation
  • Toshiba International Corporation
• 主要产品系列

第十三章附录

• 讨论指南
• 关于许可证和定价

[193 Pages Report] The Acute Ischemic Stroke Diagnosis Market size was estimated at USD 1.98 billion in 2023 and expected to reach USD 2.10 billion in 2024, at a CAGR 6.15% to reach USD 3.02 billion by 2030.

Global Acute Ischemic Stroke Diagnosis Market

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Acute Ischemic Stroke Diagnosis Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Acute Ischemic Stroke Diagnosis Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Acute Ischemic Stroke Diagnosis Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, BIOTRONIK SE & Co KG, Boehringer Ingelheim International GmbH, Boston Scientific Corporation, Canon Medical Systems Corporation, F. Hoffmann-La Roche Ltd, Fujifilm Holdings Corporation, GE Healthcare Technologies Inc., Genentech, Inc., Hitachi, Ltd., Integral Diagnostics (IDX) Group, Koninklijke Philips N.V., Mediso Kft., Medtronic PLC, Memorial Health, Neusoft Medical Systems Co., Ltd., Nihon Kohden Corporation, Planmed Oy, Samsung Electronics Co. Ltd, Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Shimadzu Corporation, Siemens Healthineers company, Stryker Corporation, and Toshiba International Corporation.

Market Segmentation & Coverage

This research report categorizes the Acute Ischemic Stroke Diagnosis Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Diagnostics
  • Carotid Ultrasound
  • Cerebral Angiography
  • Computed Tomography
  • Echocardiography
  • Electrocardiography
  • Magnetic Resonance Imaging
• End-Use
  • Hospitals
  • Research & Diagnostic Centers
• Region
  • Americas
    • Argentina
    • Brazil
    • Canada
    • Mexico
    • United States
      • California
      • Florida
      • Illinois
      • New York
      • Ohio
      • Pennsylvania
      • Texas
  • Asia-Pacific
    • Australia
    • China
    • India
    • Indonesia
    • Japan
    • Malaysia
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam
  • Europe, Middle East & Africa
    • Denmark
    • Egypt
    • Finland
    • France
    • Germany
    • Israel
    • Italy
    • Netherlands
    • Nigeria
    • Norway
    • Poland
    • Qatar
    • Russia
    • Saudi Arabia
    • South Africa
    • Spain
    • Sweden
    • Switzerland
    • Turkey
    • United Arab Emirates
    • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Acute Ischemic Stroke Diagnosis Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Acute Ischemic Stroke Diagnosis Market?

3. What are the technology trends and regulatory frameworks in the Acute Ischemic Stroke Diagnosis Market?

4. What is the market share of the leading vendors in the Acute Ischemic Stroke Diagnosis Market?

5. Which modes and strategic moves are suitable for entering the Acute Ischemic Stroke Diagnosis Market?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Limitations
• 1.7. Assumptions
• 1.8. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

• 4.1. Introduction
• 4.2. Acute Ischemic Stroke Diagnosis Market, by Region

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing number of acute stroke cases all over the globe
    • 5.1.1.2. High preference for early clinical diagnostics among consumers
    • 5.1.1.3. Rising growth of neurological imaging and diagnostics facilities
  • 5.1.2. Restraints
    • 5.1.2.1. Associated high cost of diagnostic equipments
  • 5.1.3. Opportunities
    • 5.1.3.1. Integration of robotics and AI for advanced diagnostics
    • 5.1.3.2. Ongoing research and development activities for advanced diagnostics
  • 5.1.4. Challenges
    • 5.1.4.1. Dearth of technical expertise and practical experience
• 5.2. Market Segmentation Analysis
• 5.3. Market Trend Analysis
• 5.4. Cumulative Impact of High Inflation
• 5.5. Porter's Five Forces Analysis
  • 5.5.1. Threat of New Entrants
  • 5.5.2. Threat of Substitutes
  • 5.5.3. Bargaining Power of Customers
  • 5.5.4. Bargaining Power of Suppliers
  • 5.5.5. Industry Rivalry
• 5.6. Value Chain & Critical Path Analysis
• 5.7. Regulatory Framework

6. Acute Ischemic Stroke Diagnosis Market, by Diagnostics

• 6.1. Introduction
• 6.2. Carotid Ultrasound
• 6.3. Cerebral Angiography
• 6.4. Computed Tomography
• 6.5. Echocardiography
• 6.6. Electrocardiography
• 6.7. Magnetic Resonance Imaging

7. Acute Ischemic Stroke Diagnosis Market, by End-Use

• 7.1. Introduction
• 7.2. Hospitals
• 7.3. Research & Diagnostic Centers

8. Americas Acute Ischemic Stroke Diagnosis Market

• 8.1. Introduction
• 8.2. Argentina
• 8.3. Brazil
• 8.4. Canada
• 8.5. Mexico
• 8.6. United States

9. Asia-Pacific Acute Ischemic Stroke Diagnosis Market

• 9.1. Introduction
• 9.2. Australia
• 9.3. China
• 9.4. India
• 9.5. Indonesia
• 9.6. Japan
• 9.7. Malaysia
• 9.8. Philippines
• 9.9. Singapore
• 9.10. South Korea
• 9.11. Taiwan
• 9.12. Thailand
• 9.13. Vietnam

10. Europe, Middle East & Africa Acute Ischemic Stroke Diagnosis Market

• 10.1. Introduction
• 10.2. Denmark
• 10.3. Egypt
• 10.4. Finland
• 10.5. France
• 10.6. Germany
• 10.7. Israel
• 10.8. Italy
• 10.9. Netherlands
• 10.10. Nigeria
• 10.11. Norway
• 10.12. Poland
• 10.13. Qatar
• 10.14. Russia
• 10.15. Saudi Arabia
• 10.16. South Africa
• 10.17. Spain
• 10.18. Sweden
• 10.19. Switzerland
• 10.20. Turkey
• 10.21. United Arab Emirates
• 10.22. United Kingdom

11. Competitive Landscape

• 11.1. FPNV Positioning Matrix
• 11.2. Market Share Analysis, By Key Player
• 11.3. Competitive Scenario Analysis, By Key Player

12. Competitive Portfolio

• 12.1. Key Company Profiles
  • 12.1.1. Abbott Laboratories
  • 12.1.2. BIOTRONIK SE & Co KG
  • 12.1.3. Boehringer Ingelheim International GmbH
  • 12.1.4. Boston Scientific Corporation
  • 12.1.5. Canon Medical Systems Corporation
  • 12.1.6. F. Hoffmann-La Roche Ltd
  • 12.1.7. Fujifilm Holdings Corporation
  • 12.1.8. GE Healthcare Technologies Inc.
  • 12.1.9. Genentech, Inc.
  • 12.1.10. Hitachi, Ltd.
  • 12.1.11. Integral Diagnostics (IDX) Group
  • 12.1.12. Koninklijke Philips N.V.
  • 12.1.13. Mediso Kft.
  • 12.1.14. Medtronic PLC
  • 12.1.15. Memorial Health
  • 12.1.16. Neusoft Medical Systems Co., Ltd.
  • 12.1.17. Nihon Kohden Corporation
  • 12.1.18. Planmed Oy
  • 12.1.19. Samsung Electronics Co. Ltd
  • 12.1.20. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • 12.1.21. Shimadzu Corporation
  • 12.1.22. Siemens Healthineers company
  • 12.1.23. Stryker Corporation
  • 12.1.24. Toshiba International Corporation
• 12.2. Key Product Portfolio

13. Appendix

• 13.1. Discussion Guide
• 13.2. License & Pricing

LIST OF FIGURES

• FIGURE 1. ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET RESEARCH PROCESS
• FIGURE 2. ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, 2023 VS 2030
• FIGURE 3. ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
• FIGURE 5. ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET DYNAMICS
• FIGURE 7. ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DIAGNOSTICS, 2023 VS 2030 (%)
• FIGURE 8. ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DIAGNOSTICS, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 9. ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
• FIGURE 10. ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 11. AMERICAS ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 12. AMERICAS ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 13. UNITED STATES ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 14. UNITED STATES ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 15. ASIA-PACIFIC ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 16. ASIA-PACIFIC ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 17. EUROPE, MIDDLE EAST & AFRICA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 18. EUROPE, MIDDLE EAST & AFRICA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 19. ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET, FPNV POSITIONING MATRIX, 2023
• FIGURE 20. ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SHARE, BY KEY PLAYER, 2023

LIST OF TABLES

• TABLE 1. ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 6. ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY CAROTID ULTRASOUND, BY REGION, 2018-2030 (USD MILLION)
• TABLE 7. ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY CEREBRAL ANGIOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 8. ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY COMPUTED TOMOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY ECHOCARDIOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY ELECTROCARDIOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 13. ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY RESEARCH & DIAGNOSTIC CENTERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. AMERICAS ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 16. AMERICAS ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 17. AMERICAS ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 18. ARGENTINA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 19. ARGENTINA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 20. BRAZIL ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 21. BRAZIL ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 22. CANADA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 23. CANADA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 24. MEXICO ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 25. MEXICO ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 26. UNITED STATES ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 27. UNITED STATES ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 28. UNITED STATES ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 29. ASIA-PACIFIC ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 30. ASIA-PACIFIC ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 31. ASIA-PACIFIC ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 32. AUSTRALIA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 33. AUSTRALIA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 34. CHINA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 35. CHINA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 36. INDIA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 37. INDIA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 38. INDONESIA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 39. INDONESIA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 40. JAPAN ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 41. JAPAN ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 42. MALAYSIA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 43. MALAYSIA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 44. PHILIPPINES ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 45. PHILIPPINES ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 46. SINGAPORE ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 47. SINGAPORE ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 48. SOUTH KOREA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 49. SOUTH KOREA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 50. TAIWAN ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 51. TAIWAN ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 52. THAILAND ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 53. THAILAND ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 54. VIETNAM ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 55. VIETNAM ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 56. EUROPE, MIDDLE EAST & AFRICA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 57. EUROPE, MIDDLE EAST & AFRICA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 58. EUROPE, MIDDLE EAST & AFRICA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 59. DENMARK ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 60. DENMARK ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 61. EGYPT ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 62. EGYPT ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 63. FINLAND ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 64. FINLAND ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 65. FRANCE ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 66. FRANCE ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 67. GERMANY ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 68. GERMANY ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 69. ISRAEL ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 70. ISRAEL ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 71. ITALY ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 72. ITALY ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 73. NETHERLANDS ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 74. NETHERLANDS ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 75. NIGERIA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 76. NIGERIA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 77. NORWAY ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 78. NORWAY ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 79. POLAND ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 80. POLAND ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 81. QATAR ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 82. QATAR ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 83. RUSSIA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 84. RUSSIA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 85. SAUDI ARABIA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 86. SAUDI ARABIA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 87. SOUTH AFRICA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 88. SOUTH AFRICA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 89. SPAIN ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 90. SPAIN ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 91. SWEDEN ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 92. SWEDEN ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 93. SWITZERLAND ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 94. SWITZERLAND ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 95. TURKEY ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 96. TURKEY ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 97. UNITED ARAB EMIRATES ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 98. UNITED ARAB EMIRATES ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 99. UNITED KINGDOM ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 100. UNITED KINGDOM ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 101. ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET, FPNV POSITIONING MATRIX, 2023
• TABLE 102. ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 103. ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET LICENSE & PRICING